C84.19
Sézary disease, extranodal and solid organ sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Sézary disease is a rare type of blood cancer classified under cutaneous T-cell lymphoma. It primarily affects the skin but can also involve the bloodstream and other organs. The condition is characterized by the presence of Sézary cells, which are abnormal T-lymphocytes. When this disease spreads beyond the skin to extranodal or solid organ sites, it is classified under ICD-10 code C84.19. Recognizing the symptoms and understanding its nature can help in early diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting T-cells Unknown exact etiology, but possible genetic and environmental factors Increased proliferation of malignant T-cells leading to their accumulation in the skin and bloodstream Potential associations with immune system dysfunction
Key Symptoms: Persistent redness, rash, or scaling of the skin Generalized skin itching and discomfort Presence of Sézary cells in the blood Swelling of lymph nodes Unexplained weight loss or fatigue Infections due to immune system impairment Involvement of other organs may cause additional symptoms, such as abdominal pain or organ-specific signs
Diagnostic & Treatment
Diagnosis Path: Diagnosing Sézary disease involves a combination of clinical assessment, laboratory tests, and biopsy procedures. Typical steps include:
Treatment Protocols: Treatment strategies aim to control symptoms, reduce the number of malignant cells, and improve quality of life. Options include:
Clinical Advice & FAQs
Billing Guidance
Is C84.19 a billable ICD-10 code?
Yes, C84.19 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.19?
Clinical documentation must specify the nature of Sézary disease, extranodal and solid organ sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference